(Reuters) -Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is preparing to leave early next year.

Dec 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is ...

(Reuters) -Gilead Sciences said on Thursday it has appointed Sanofi (NASDAQ:SNY)'s Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is preparing to leave early ...

Gilead Sciences has raided Sanofi for its next chief medical officer, luring Dietmar Berger, M.D., Ph.D., away from the French drugmaker to replace Merdad Parsey, M.D ...

(Reuters) -Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent Merdad Parsey, who is preparing to leave early next year. Berger, ...

Gilead (GILD) announced that Dietmar Berger will join the company ... the company’s therapeutic areas of focus. Prior to Sanofi, Berger served in senior development roles at Atara, Genentech ...

Gilead Sciences has appointed Dietmar Berger as chief medical officer and a member of its ... He most recently served as chief medical officer and global head of development at Sanofi, which saw him ...